dc.contributor.author | Biljak, Vanja Radišić | |
dc.contributor.author | Aakre, Kristin Moberg | |
dc.contributor.author | Yucel, Dogan | |
dc.contributor.author | Bargnoux, Anne-Sophie | |
dc.contributor.author | Cristol, Jean-Paul | |
dc.contributor.author | Piéroni, Laurence | |
dc.date.accessioned | 2021-02-01T14:45:15Z | |
dc.date.available | 2021-02-01T14:45:15Z | |
dc.date.issued | 2017-12-01 | |
dc.identifier.other | 29333148 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12591/544 | |
dc.description.abstract | The principal benefit of guidelines is to improve the quality of care received by patients. In the 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (KDIGO) was released and it is designed to provide information and assist decision making. This review gives a brief overview of a various national CKD guidelines that rely on the newly released KDIGO guidelines. All of the included countries (France, Turkey, Norway and Croatia) are non-English speaking countries and they differ in population and socio economic aspects. Examples shown in this review may provide valuable experience for countries that are in process of creating their national CKD guidelines. | en_US |
dc.publisher | Tıp Fakültesi | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.title | A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries. | en_US |
dc.contributor.department | Biyokimya | en_US |